Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 3/2019

Inhalt (25 Artikel)

Open Access Original Article – Cancer Research

Radiomics-based machine learning methods for isocitrate dehydrogenase genotype prediction of diffuse gliomas

Shuang Wu, Jin Meng, Qi Yu, Ping Li, Shen Fu

Original Article – Cancer Research

Patient-derived, three-dimensional spheroid cultures provide a versatile translational model for the study of organ-confined prostate cancer

Johannes Linxweiler, Markus Hammer, Stefanie Muhs, Moritz Kohn, Alexej Pryalukhin, Christian Veith, Rainer M. Bohle, Michael Stöckle, Kerstin Junker, Matthias Saar

Original Article – Cancer Research

Clinical and biological characteristics of myeloma patients influence response to elotuzumab combination therapy

Sophia Danhof, Susanne Strifler, Dorothea Hose, Martin Kortüm, Max Bittrich, Jochen Hefner, Hermann Einsele, Stefan Knop, Martin Schreder

Original Article – Cancer Research

Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway

Yang Su, Jingxiao Lu, Xianguo Chen, Chaozhao Liang, Pengcheng Luo, Cong Qin, Jie Zhang

Original Article – Cancer Research

Melanoma tumour vasculature heterogeneity: from mice models to human

Vincent Pautu, Adélie Mellinger, Pauline Resnier, Elise Lepeltier, Ludovic Martin, Lise Boussemart, Franck Letournel, Catherine Passirani, Nicolas Clere

Open Access Original Article – Cancer Research

PTPN2 deficiency along with activation of nuclear Akt predict endocrine resistance in breast cancer

Elin Karlsson, Cynthia Veenstra, Jon Gårsjö, Bo Nordenskjöld, Tommy Fornander, Olle Stål

Original Article – Cancer Research

Effect of the botanical formula LCS101 on the anti-cancer effects of radiation therapy

Zoya Cohen, Noah Samuels, Yair Maimon, Raanan Berger

Original Article – Cancer Research

T-cell receptor-α CDR3 domain chemical features correlate with survival rates in bladder cancer

Boris I. Chobrutskiy, Saif Zaman, Andrea Diviney, Moody M. Mihyu, George Blanck

Open Access Original Article – Cancer Research

LncRNA GAS5 regulates redox balance and dysregulates the cell cycle and apoptosis in malignant melanoma cells

Long Chen, Huixin Yang, Zihan Yi, Lu Jiang, Yuqian Li, Qiaoqiao Han, Yuye Yang, Qiao Zhang, Zhe Yang, Yingmin Kuang, Yuechun Zhu

Original Article – Cancer Research

Increasing trends in in situ breast cancer incidence in a region with no population-based mammographic screening program: results from Zurich, Switzerland 2003–2014

Nena Karavasiloglou, Katarina L. Matthes, Claudia Berlin, Manuela Limam, Miriam Wanner, Dimitri Korol, Sabine Rohrmann

Original Article – Cancer Research

ZWINT is the next potential target for lung cancer therapy

Fang Peng, Qiang Li, Shao-Qing Niu, Guo-Ping Shen, Ying Luo, Ming Chen, Yong Bao

Original Article – Cancer Research

Identification of genes and pathways, including the CXCL2 axis, altered by DNA methylation in hepatocellular carcinoma

Sophia Subat, Kaoru Mogushi, Mahmut Yasen, Takashi Kohda, Yuichi Ishikawa, Hiroshi Tanaka

Original Article – Cancer Research

FTIR-based spectrum of salivary exosomes coupled with computational-aided discriminating analysis in the diagnosis of oral cancer

Ayelet Zlotogorski-Hurvitz, Ben Zion Dekel, Dov Malonek, Ran Yahalom, Marilena Vered

Review – Clinical Oncology

Mistletoe in oncological treatment: a systematic review

M. Freuding, C. Keinki, O. Micke, J. Buentzel, Jutta Huebner

Original Article – Clinical Oncology

Treatment outcomes of intracranial germinoma: a retrospective analysis of 170 patients from a single institution

Xin Lian, Xiaorong Hou, Junfang Yan, Shuai Sun, Zheng Miao, Zhikai Liu, Weiping Wang, Jing Shen, Jie Shen, Ke Hu, Fuquan Zhang

Original Article – Clinical Oncology

Everolimus in patients with multiply relapsed or cisplatin refractory germ cell tumors: results of a phase II, single-arm, open-label multicenter trial (RADIT) of the German Testicular Cancer Study Group

Martin Fenner, Christoph Oing, Annette Dieing, Thomas Gauler, Karin Oechsle, Anja Lorch, Marcus Hentrich, Hans-Georg Kopp, Carsten Bokemeyer, Friedemann Honecker

Original Article – Clinical Oncology

Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (version 2018)

Jianmin Xu, Jia Fan, Xinyu Qin, Jianqiang Cai, Jin Gu, Shan Wang, Xishan Wang, Suzhan Zhang, Zhongtao Zhang, Yi Ba, Jianhong Bu, Jianhui Cai, Sanjun Cai, Shan Zeng, Zhaochong Zeng, Gong Chen, Yu Chen, Zihua Chen, Zongyou Chen, Jiemin Cheng, Pan Chi, Guanghai Dai, Yong Dai, Yanhong Deng, Kefeng Ding, Xuedong Fang, Chuangang Fu, Jianping Gong, Chunyi Hao, Yulong He, Zhongcheng Huang, Jiafu Ji, Baoqing Jia, Kewei Jiang, Jing Jin, Dalu Kong, Ping Lan, Dechuan Li, Guoli Li, Jin Li, Leping Li, Yunfeng Li, Zhixia Li, Houjie Liang, Xiaobo Liang, Feng Lin, Jianjiang Lin, Hongjun Liu, Tianshu Liu, Yunpeng Liu, Hongming Pan, Zhizhong Pan, Haiping Pei, Tao Peng, Li Ren, Lin Shen, Chun Song, Tianqiang Song, Xiangqian Su, Yihong Sun, Min Tao, Liguo Tian, Desen Wan, Jianping Wang, Guiying Wang, Guiyu Wang, Haijiang Wang, Jianhua Wang, Lei Wang, Xin Wang, Yajie Wang, Yi Wang, Ziqiang Wang, Ye Wei, Dong Wei, Feng Xia, Jianguo Xia, Lijian Xia, Baocai Xing, Bin Xiong, Jianming Xu, Nong Xu, Ruihua Xu, Ye Xu, Zekuan Xu, Zhongfa Xu, Shujun Yang, Hongwei Yao, Yingjiang Ye, Peiwu Yu, Ying Yuan, Jun Zhang, Keliang Zhang, Wei Zhang, Xiaotian Zhang, Yanqiao Zhang, Youcheng Zhang, Zhen Zhang, Qingchuan Zhao, Ren Zhao, Shu Zheng, Aiping Zhou, Jian Zhou, Zongguang Zhou

Original Article – Clinical Oncology

Impact of the homogeneous and heterogeneous risk factors on the incidence and survival outcome of bone metastasis in NSCLC patients

Qian Song, Jun Shang, Chufan Zhang, Lanlin Zhang, Xianghua Wu

Original Article – Clinical Oncology

Comparative analysis of co-occurring mutations of specific tumor suppressor genes in lung adenocarcinoma between Asian and Caucasian populations

Yiliang Zhang, Yuan Ma, Yuan Li, Xuxia Shen, Yongfu Yu, Yunjian Pan, Yang Zhang, Difan Zheng, Yue Zhao, Ting Ye, Bin Li, Hong Hu, Yihua Sun, Yawei Zhang, Jiaqing Xiang, Haiquan Chen

Original Article – Clinical Oncology

FDG PET/CT to predict the curability of endoscopic resection for early gastric cancer

Hyun Woo Chung, Jeong Hwan Kim, In-Kyung Sung, Sun-Young Lee, Hyung Seok Park, Chan Sup Shim, Ho Yoon Bang, Young So, Eun Jeong Lee

Open Access Original Article – Clinical Oncology

ePROs in the follow-up of cancer patients treated with immune checkpoint inhibitors: a retrospective study

Sanna Iivanainen, Tuomo Alanko, Katriina Peltola, Teemu Konkola, Jussi Ekström, Henri Virtanen, Jussi P. Koivunen

Original Article – Clinical Oncology

Effects of metabolic syndrome on the prevalence of prostate cancer: historical cohort study using the national health insurance service database

Sangjun Yoo, Sohee Oh, Juhyun Park, Sung Yong Cho, Min Chul Cho, Hwancheol Son, Hyeon Jeong

Original Article – Clinical Oncology

Pre-orchiectomy tumor marker levels should not be used for International Germ Cell Consensus Classification (IGCCCG) risk group assignment

Christian Daniel Fankhauser, Travis A. Gerke, Lisa Roth, Sophia Sander, Nico Christian Grossmann, Benedikt Kranzbühler, Daniel Eberli, Tullio Sulser, Joerg Beyer, Thomas Hermanns

Original Article – Clinical Oncology

Serum miR-16 as a potential biomarker for human cancer diagnosis: results from a large-scale population

Zebo Huang, Wenjiao Chen, Yiping Du, Qin Guo, Yong Mao, Xin Zhou, Dong Hua

Neu im Fachgebiet Onkologie

Informierte Frauen neigen zu späterem Mammografie-Screening

Frauen in ihren 40ern, die über die Vor- und Nachteile des Mammografie-Screenings auf Brustkrebs informiert werden, neigen stärker dazu, den Screeningbeginn nach hinten zu verschieben. Die Mehrheit aber nähme das Angebot an, wie eine US-Studie zeigt.

Endometriose-Subtypen und das Risiko für Ovarialkarzinome

19.07.2024 Ovarialkarzinom Nachrichten

US-Kohortendaten sprechen dafür, dass verschiedene Endometrioseformen unterschiedlich mit dem Risiko für Ovarialkarzinome assoziiert sind. Besonders erhöht ist das Risiko offenbar bei tief infiltrierenden und ovariellen Endometrioseformen.

Die zelluläre Differenzierung wird wiederhergestellt

18.07.2024 Akute myeloische Leukämie Nachrichten

Ivosidenib von Servier ist ein Inhibitor der mutierten Isoform der Isocitrat-Dehydrogenase-1 (IDH1) und wird zur Behandlung von Patientinnen und Patienten mit neu diagnostizierter akuter myeloischer Leukämie (AML) eingesetzt. Die Substanz sorgt für die Wiederherstellung der zellulären Differenzierung.

Weißer Hautkrebs: Ein Update zu Diagnostik und Therapie

18.07.2024 Fortbildungswoche 2024 Kongressbericht

In der aktualisierten Version der S3-Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ gibt es neue Empfehlungen, unter anderem zu erweiterten Optionen bei aktinischer Keratose sowie zur systemischen und chirurgischen Behandlung von Plattenepithelkarzinomen. Ein Überblick.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.